FDA clears the way for additional bivalent boosters for certain vulnerable individuals

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain people with weakened immunity to get additional doses before this fall’s vaccination campaigns.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

TOP STORIES